Cargando…
The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease
Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are the analysis of cerebral spinal fluid (CSF) to detect levels of Aβ42 and phosphorylated-tau, amyloid and FDG-PET, and MRI volumetry. Some of these procedures are still invasive for patients or expensive...
Autores principales: | Maestú, Fernando, Cuesta, Pablo, Hasan, Omar, Fernandéz, Alberto, Funke, Michael, Schulz, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374629/ https://www.ncbi.nlm.nih.gov/pubmed/30792632 http://dx.doi.org/10.3389/fnhum.2019.00017 |
Ejemplares similares
-
Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease
por: Maestú, Fernando, et al.
Publicado: (2019) -
Noise characteristics in spaceflight multichannel EEG
por: Fiedler, Patrique, et al.
Publicado: (2023) -
Effects of spaceflight on the EEG alpha power and functional connectivity
por: Pusil, Sandra, et al.
Publicado: (2023) -
How to Build a Functional Connectomic Biomarker for Mild Cognitive Impairment From Source Reconstructed MEG Resting-State Activity: The Combination of ROI Representation and Connectivity Estimator Matters
por: Dimitriadis, Stavros I., et al.
Publicado: (2018) -
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)